SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BSD Medical (Long Term Investment Oriented)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: pleonastic who wrote (61)1/10/2013 12:02:08 PM
From: geoffrey Wren1 Recommendation  Read Replies (1) of 178
 
BSDM earnings out.

Loss of $2.2M, slightly less on cash flow. If nothing changes there are due for a secondary within 6 months or so. You cannot wait until you are down to your last million before doing the secondary. If things are looking up, they would want to defer the secondary until they could get a better price per share.

They stated: "We recently shipped a new BSD-500 Hyperthermia System and we currently have additional sales backlog of four hyperthermia systems which we will deliver in fiscal 2013,” said Harold Wolcott, President of the Company. “We are encouraged by the progress we have made in our MicroThermX® Microwave Ablation System (“MicroThermX®”) business. We experienced a 586% increase in sales for the MicroThermX® product line for the fiscal quarter ended November 30, 2012, as compared to the fiscal quarter ended November 30, 2011."

The big question is how this quarter's sales of MicroThermX products is shaping up in comparison to last quarter's. No hint on that.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext